Amphastar Pharmaceuticals Inc. (AMPH)
NASDAQ · Healthcare
Amphastar Pharmaceuticals Inc. Gross Profit 2012–2025
Amphastar Pharmaceuticals Inc. annual/quarterly gross profit history and growth rate from 2012 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Amphastar Pharmaceuticals Inc. gross profit for the quarter ending March 31, 2026 was 70.3 M, a 17.51% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. gross profit for the twelve months ending March 31, 2026 was 340.7 M, a 13.88% decrease year-over-year.
- Amphastar Pharmaceuticals Inc. annual gross profit for 2025 was 356.1 M, a 4.76% decrease from 2024.
- Amphastar Pharmaceuticals Inc. annual gross profit for 2024 was 373.9 M, a 6.47% increase from 2023.
- Amphastar Pharmaceuticals Inc. annual gross profit for 2023 was 351.1 M, a 41.09% increase from 2022.
- Amphastar Pharmaceuticals Inc. annual gross profit for 2022 was 248.9 M.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Amphastar Pharmaceuticals Inc. Gross Profit — FAQ
Amphastar Pharmaceuticals Inc. (AMPH) gross profit over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Amphastar Pharmaceuticals Inc.'s gross profit?
Amphastar Pharmaceuticals Inc. (AMPH) reported gross profit of $356M for fiscal 2025.
Where can I see AMPH's gross profit history?
The chart and table above show Amphastar Pharmaceuticals Inc.'s gross profit by year and by quarter, including the growth rate.